HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


European Commission following REACH

This article was originally published in The Rose Sheet

Executive Summary

Commissioner for Industry and Entrepreneurship Antonio Tajani and Environment Commissioner Janez Potocnik visited the European Chemicals Agency March 25 and met with stakeholders in advance of Nov. 30 REACH deadline for registration of chemicals manufactured or imported in volumes equal to or greater than 1,000 tons annually, as well as CMR substances, or those identified as potentially carcinogenic, mutagenic or reprotoxic. Chemicals management is of "very high concern," and finding solutions to practical problems - particularly issues that make the process difficult for small and medium enterprises - is a priority, EC leaders indicate. A Directors Contact Group has been devised to monitor industry's progress. "REACH ensures a high level of protection of human health and the environment while also playing an important role to encourage innovation, foster competitiveness and better enable enterprises [to] meet essential demands of consumers," states Tajani. Geert Dancet, executive director of ECHA, says EC chiefs' active involvement "signals that the Commission and ECHA stand side-by-side in making REACH work." ECHA and EC have agreed to expand "candidate list" for substances of very high concern from 29 to 106 substances by 2012. The agency's first progress report includes recommendations for the improvement of registration dossiers (1"The Rose Sheet" March 29, 2010)

You may also be interested in...

ECHA Offers REACH Progress Report, Urging Registrants To Improve Dossiers

By the end of 2009, the European Chemicals Agency had completed 15 of 30 "compliance checks" initiated since registration dossiers started dribbling in under REACH, and almost half of its checks have inspired quality observation letters due to inadequacies, the agency says

On CRN Challenge, Nexus Formulas Gets Lesson On Supporting Ad Claims For Supplements

So full of errors were the firm's online ads for its Plavinol supplement, the National Advertising Division noted support for some claims contained "many of the same flaws" as others. The prevalence of problems prompted NAD to go its "scope of review" and note unclear instructions on Plavinol labels.

FDA’s Cannabidiol Crackdown: What Do Warning Letters Say About CBD In Cosmetics?

Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts